18F-FDG-PET-CT in patients with differentiated thyroid carcinoma, elevated thyroglobulin and negative 131I scan

被引：0
|
作者：
Mendez, D. R. [1 ]
Rodado, S. [1 ]
Santos, I. [1 ]
Hernandez, I. [1 ]
Couto, R. [1 ]
Marin, M. [1 ]
Coronado, M. [1 ]
Martin Curto, L. [1 ]
机构：
[1] Univ Hosp La Paz, Madrid, Spain
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2012年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P0934
引用
收藏
页码：S563 / S563
页数：1
相关论文
共 50 条
  • [1] Impact of FDG PET on patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative 131I scan
    Schlüter, B
    Bohuslavizki, KH
    Beyer, W
    Plotkin, M
    Buchert, R
    Clausen, M
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (01) : 71 - 76
  • [2] 18F-FDG PET-CT in differentiated thyroid carcinoma with negative 131I post-therapy whole body scan and elevated TSH-stimulated thyroglobulin
    Salvatori, M.
    Mazza, R.
    Baldari, G.
    Basile, P.
    Maussier, M. L.
    Perotti, G.
    Giordano, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S266 - S266
  • [3] Can 18F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?
    Bannas, Peter
    Derlin, Thorsten
    Groth, Michael
    Apostolova, Ivayla
    Adam, Gerhard
    Mester, Janos
    Klutmann, Susanne
    [J]. ANNALS OF NUCLEAR MEDICINE, 2012, 26 (01) : 77 - 85
  • [4] Can 18F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?
    Peter Bannas
    Thorsten Derlin
    Michael Groth
    Ivayla Apostolova
    Gerhard Adam
    Janos Mester
    Susanne Klutmann
    [J]. Annals of Nuclear Medicine, 2012, 26 : 77 - 85
  • [5] 131I whole-body scan or 18FDG PET/CT for patients with elevated thyroglobulin and negative ultrasound?
    Treglia G.
    Bertagna F.
    Piccardo A.
    Giovanella L.
    [J]. Clinical and Translational Imaging, 2013, 1 (3) : 175 - 183
  • [6] Value of 18F-FDG Hybrid PET/MR in Differentiated Thyroid Cancer Patients with Negative 131I Whole-Body Scan and Elevated Thyroglobulin Levels
    Li, Hongyan
    Chen, Xiaomin
    Zhang, Yajing
    Wang, Kun
    Gao, Zairong
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2869 - 2876
  • [7] The utility of 18F-FDG-PET/CT in differentiated thyroid cancer patients and elevated thyroglobulin after total thyroidectomy and 131I ablation
    Mladenov, K.
    Spassov, B.
    Vassileva, D.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S368 - S368
  • [8] 18F-FDG PET/CT and ultrasonogrpahy in differentiated thyroid carcinoma patients with elevated serum levels of antithyroglobulin antibody, negative Tg and whole body 131I scan
    Liu, Jiao
    Liu, Baoping
    Yu, Yanxia
    Chao, Fangfang
    Liu, Yan
    Han, Xingmin
    [J]. HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2018, 21 (01): : 24 - 27
  • [9] Role of PET/CT 18F-FDG in the assessment of differentiated thyroid cancer in patients with negative 131I post-therapy whole body scan and elevated serum thyroglobulin levels
    Vieira, F.
    Azevedo-Silva, F.
    Parracho, M.
    Costa, G.
    Lapa, P.
    Albuquerque, A.
    Pedroso-Lima, J.
    Ferrer-Antunes, A. I.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S121 - S121
  • [10] Stratification of recurrent differentiated thyroid cancer with elevated thyroglobulin and negative I-131 whole body scan by restaging 18F FDG PET/CT
    Okuyucu, K.
    Ince, S.
    Alagoz, E.
    Emer, O.
    San, H.
    Balkan, E.
    Ayan, A.
    Gunalp, B.
    Karacalioglu, A. O.
    Arslan, N.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S649 - S650
12345